At the news
? BULLISHIMPACT 6/10 PRESS-RELEASE filed Nov 4, 2026 at 16:01 ET
Progyny reported Q3 2026 revenue of $341.3M (+8.9% YoY) and adjusted EPS of $0.52, beating the $0.51 consensus. The company raised the midpoint of its full-year 2026 revenue guidance to $1.365B-$1.385B and adjusted EPS to $2.09-$2.13, driven by a record selling season adding 1.3M new covered lives and near-100% retention.
- Q3 2026 revenue $341.3M, +8.9% YoY, vs consensus $340.8M
- Q3 2026 adjusted EPS $0.52, vs consensus $0.51
- GAAP diluted EPS $0.32, vs $0.15 YoY
- Gross margin 24.5%, up from 23.2% YoY
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access